Arcadia Biosciences (RKDA) Tops Q2 EPS by 78c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of $0.61, $0.78 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Wolfe Research Starts Federal Realty Investment Trust (FRT) at Outperform